年轻女性不太可能处方或采取心脏病发作药物

根据美国心脏协会杂志的新研究报告，少女比年轻人在心脏病发表的情况下填写或填补他们的用药循环:心血管质量和结果。

建议男性和女性都可以心脏病发作幸存者服用血管紧张素转换酶抑制剂、受体阻滞剂和他汀类药物以防止再次心脏病发作。然而，研究表明，女性使用药物预防心脏病复发的比例低于男性。

“可能有两个原因为什么女人比男人承受更少的心血管药物在一个门诊,”凯特Smolina说,博士,研究报告的主要作者和博士后药物制药政策中心的卫生服务和政策研究,英属哥伦比亚大学,加拿大温哥华。“这要么是医生开药行为的后果，要么是病人不服药，或者两者兼有。”

研究人员分析了超过12000人的数据心脏病患者在2007 - 09年期间，在加拿大英国哥伦比亚幸存下来至少一年。

他们发现:

离开医院后，只有三分之一的心脏病幸存者在至少80%的时间里服用了所有合适的处方。

在55岁以下的女性中，只有65%的人在心脏病发作后开始使用所有适当的药物进行治疗，而在同年龄段的男性中，这一比例为75%。男性和女性在坚持治疗方面没有差异;换句话说，一旦接受治疗，男性和女性继续或退出的比例是相同的。

“开始治疗的性别差异年轻的女人is an important finding because younger women have much worse outcomes after suffering a heart attack than do men of the same age," said Karin Humphries, M.B.A., D.Sc., study co-author and associate professor of Cardiology at the University of British Columbia. "This finding suggests that younger women should be treated aggressively, especially when we have medications that work."

Although researchers were unable to clearly determine whether the gender-based differences in treatment initiation were driven by physician prescribing practices or patient behavior (i.e. younger women might have been less likely to fill written prescriptions), researchers believe more focus is needed in treating young women after a heart attack.

“对于医生和病人来说，摆脱心脏病是男性疾病的传统观念是很重要的，”斯摩利纳说。“心脏病年轻的女士最近才得到研究的关注，所以医生和患者可能仍然有不正确的看法，认为这些心脏病药物对年轻人有风险女性”。

Nadia Khan, MSc, M.D., another study co-author and a general internist at St. Paul's Hospital in Vancouver, Canada notes that patients should ask their physicians if they have been prescribed all of the medications that are known to benefit heart attack survivors, keep themselves informed about therapies and what they are used for by visiting the American Heart Association websites or other trusted heart health information resources, and make sure they take their medication as directed.

---

---